AdaptHealth (AHCO) Net Income towards Common Stockholders Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | AdaptHealth | 1.35 Bn | 1.31 Bn | 111.50 Mn | -143.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.19% |
| Dec 31, 2025 | -297.64% |
| Sep 30, 2025 | 7.49% |
| Jun 30, 2025 | -23.09% |
| Mar 31, 2025 | -457.69% |
| Dec 31, 2024 | 120.27% |
| Sep 30, 2024 | 105.29% |
| Jun 30, 2024 | 36.82% |
| Mar 31, 2024 | -106.60% |
| Dec 31, 2023 | -15,381.01% |
| Sep 30, 2023 | -3,168.01% |
| Jun 30, 2023 | 17.09% |
| Mar 31, 2023 | 44.93% |
| Dec 31, 2022 | -103.09% |
| Sep 30, 2022 | -47.67% |
| Jun 30, 2022 | -21.61% |
| Mar 31, 2022 | 389.86% |
| Dec 31, 2021 | 165.86% |
| Sep 30, 2021 | 155.27% |
| Jun 30, 2021 | 348.37% |
| Mar 31, 2021 | 88.52% |
| Dec 31, 2020 | -551.06% |
| Sep 30, 2020 | -1,583.21% |
| Jun 30, 2020 | 312.01% |
| Mar 31, 2020 | -533.71% |
| Dec 31, 2019 | -153.98% |
| Sep 30, 2019 | -684.97% |
| Jun 30, 2019 | -349.92% |
| Mar 31, 2019 | -2,574.52% |